TY - JOUR
T1 - Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population
AU - Rubin, Jonathan
AU - Matsushita, Kunihiro
AU - Lazo, Mariana
AU - Ballantyne, Christie M.
AU - Nambi, Vijay
AU - Hoogeveen, Ron
AU - Sharrett, Albert Richey
AU - Blumenthal, Roger S.
AU - Coresh, Josef
AU - Selvin, Elizabeth
N1 - Funding Information:
Drs. Selvin and Ballantyne have served on a Roche Diagnostics Advisory Board. Drs. Hoogeveen and Ballantyne have received grant support from Roche Diagnostics (and the National Institutes of Health). The other authors declare no commercial conflicts of interest (but receive National Institutes of Health grant funding). Drs Ballantyne, Hoogeveen, and Nambi are co-investigators on a provisional patent (# 61721475) filed by Baylor and Roche for use of biomarkers in heart failure prediction.
Funding Information:
The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts ( HHSN268201100005C , HHSN268201100006C , HHSN268201100007C , HHSN268201100008C , HHSN268201100009C , HHSN268201100010C , HHSN268201100011C , and HHSN268201100012C ). The authors thank the staff and participants of the ARIC study for their important contributions. Dr. Rubin was supported by NIH/NHLBI grant T32HL007024 at the time of this work. This research was also supported by NIH/NIDDK grants R01DK089174 and K24DK106414 to Dr. Selvin. Dr. Coresh was supported by NIH and National Kidney Foundation.
Publisher Copyright:
© 2016 The Canadian Society of Clinical Chemists.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Objectives: To study the relationship between cardiovascular risk factors and detectable cardiac troponin-T using a highly sensitive assay (hs-cTnT) among persons without a history of cardiovascular disease. Design and methods: We examined the cross-sectional associations between cardiovascular risk factors and hs-cTnT in 9593 participants (mean age 65.6 (SD, 5.6), 41% female, 22% black) free of cardiovascular disease in a community-based cohort, through the Atherosclerosis Risk in Communities (ARIC) Study. We used multivariable logistic regression to characterize the association between cardiovascular risk factors and detectable (≥. 3.0 to 13.9 ng/L) and elevated (≥. 14.0 ng/L) hs-cTnT. Results: hs-cTnT was detectable in 59% and elevated in 7% of the study population. Among persons with ideal cardiovascular health, hs-cTnT was detectable in 44%. In models adjusting for significant determinants of hs-cTnT concentration, detectable hs-cTnT was more frequent among males, blacks and persons with diabetes and hypertension and less frequent among statin users, current smokers and drinkers. Other risk factors associated with detectable hs-cTnT were older age, lower kidney function and higher body mass index. These risk factors were associated with elevated hs-cTnT in a similar pattern. Conclusion: In a community-based sample without cardiovascular disease hs-cTnT is detectable in most adults, even among those with ideal cardiovascular health. Although most traditional cardiovascular risk factors were significant determinants of detectable and elevated hs-cTnT, the associations were particularly robust for sex, age, race, hypertension and diabetes.
AB - Objectives: To study the relationship between cardiovascular risk factors and detectable cardiac troponin-T using a highly sensitive assay (hs-cTnT) among persons without a history of cardiovascular disease. Design and methods: We examined the cross-sectional associations between cardiovascular risk factors and hs-cTnT in 9593 participants (mean age 65.6 (SD, 5.6), 41% female, 22% black) free of cardiovascular disease in a community-based cohort, through the Atherosclerosis Risk in Communities (ARIC) Study. We used multivariable logistic regression to characterize the association between cardiovascular risk factors and detectable (≥. 3.0 to 13.9 ng/L) and elevated (≥. 14.0 ng/L) hs-cTnT. Results: hs-cTnT was detectable in 59% and elevated in 7% of the study population. Among persons with ideal cardiovascular health, hs-cTnT was detectable in 44%. In models adjusting for significant determinants of hs-cTnT concentration, detectable hs-cTnT was more frequent among males, blacks and persons with diabetes and hypertension and less frequent among statin users, current smokers and drinkers. Other risk factors associated with detectable hs-cTnT were older age, lower kidney function and higher body mass index. These risk factors were associated with elevated hs-cTnT in a similar pattern. Conclusion: In a community-based sample without cardiovascular disease hs-cTnT is detectable in most adults, even among those with ideal cardiovascular health. Although most traditional cardiovascular risk factors were significant determinants of detectable and elevated hs-cTnT, the associations were particularly robust for sex, age, race, hypertension and diabetes.
KW - Cardiovascular disease
KW - Epidemiology
KW - Risk factors
KW - Troponin
UR - http://www.scopus.com/inward/record.url?scp=84962019999&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84962019999&partnerID=8YFLogxK
U2 - 10.1016/j.clinbiochem.2016.01.024
DO - 10.1016/j.clinbiochem.2016.01.024
M3 - Article
C2 - 26975902
AN - SCOPUS:84962019999
SN - 0009-9120
VL - 49
SP - 657
EP - 662
JO - Clinical Biochemistry
JF - Clinical Biochemistry
IS - 9
ER -